Chronic co-administration of nicotine and methamphetamine causes differential expression of immediate early genes in the dorsal striatum and nucleus accumbens of Rats

Neuroscience

Volumn 243, Issue , 2013, Pages 89-96

  Saint Preux, F ^a   Bores, L R ^a   Tulloch, I ^a   Ladenheim, B ^a   Kim, R ^b   Thanos, P K ^b   Volkow, N D ^a,b   Cadet, J L ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

Author keywords

Immediate early genes; Methamphetamine; Nicotine; Nucleus accumbens; Striatum

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 2; EARLY GROWTH RESPONSE FACTOR 3; MESSENGER RNA; METHAMPHETAMINE; NICOTINE; NUCLEAR RECEPTOR NR4A3; NUCLEAR RECEPTOR RELATED FACTOR 1; PROTEIN C FOS; TRANSCRIPTION FACTOR FOSB; TRANSCRIPTION FACTOR FRA 2; TRANSCRIPTION FACTOR JUNB;

ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; IMMEDIATE EARLY GENE; LONG TERM EXPOSURE; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; GENE EXPRESSION REGULATION; GENES, IMMEDIATE-EARLY; MALE; METHAMPHETAMINE; NICOTINE; NICOTINIC AGONISTS; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SMOKING; SUBSTANCE-RELATED DISORDERS;

EID: 84877319480     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.03.052     Document Type: Article

References (40)

1. Benowitz N.L. Nicotine addiction. N Engl J Med 2010, 362:2295-2303.
2. Benwell M.E.M., Balfour D.J.K. Regional variation in the effects of nicotine on catecholamine overflow in rat brain. Eur J Pharmacol 1997, 325:13-20.
3. Benwell M.E., Balfour D.J., et al. Desensitization of the nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine. Br J Pharmacol 1995, 114(2):454-460.
4. Bossert J.M., Wihbey K.A., Pickens C.L., Nair S.G., Shaham Y. Role of dopamine D(1)-family receptors in dorsolateral striatum in context-induced reinstatement of heroin seeking in rats. Psychopharmacology 2009, 206:51-60.
5. Brunzell D.H., Russell D.S., Picciotto M.R. In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57B1/6J mice. J Neurochem 2003, 84:1431-1441.
6. Cadet J.L., Brannock C., Krasnova I.N., Ladenheim B., McCoy M.T., Chou J., Lehrmann E., Wood W.H., Becker K.G., Wang Y. Methamphetamine-induced dopamine-independent alterations in striatal gene expression in the 6-hydroxydopamine hemiparkinsonian rats. PLoS One 2010, 5(12):e15643.
7. Cho A.K., Melega W.P. Patterns of methamphetamine abuse and their consequences. J Addict Dis 2002, 21:21-34.
8. Fuchs R.A., Branham R.K., See R.F. Different neural substrates mediate cocaine seeking after abstinence versus extinction training: a critical role for the dorsolateral caudate-putamen. J Neurosci 2006, 26:3584-3588.
9. Gatch M.B., Flores E., Forster M.J. Nicotine and methamphetamine share discriminative stimulus effects. Drug Alcohol Depend 2008, 93:63-71.
10. Ghosheh O., Dwoskin L.P., et al. Residence times and half-lives of nicotine metabolites in rat brain after acute peripheral administration of [2'-14C]nicotine. Drug Metab Dispos 1999, 27(12):1448-1455.
11. Goldsamt L.A., O'Brien J., Clatts M.C., McGuire L.S. The relationship between club drug use and other drug use: a survey of New York City middle school students. Subst Use Misuse 2005, 40:1539-1555.
12. Hamada M., Higashi H., Nairn A.C., Greengard P., Nishi A. Differential regulation of dopamine D1 and D2 signaling by nicotine in neostriatal neurons. J Neurochem 2004, 90:1094-1103.
13. Hamada M., Hendrick J.P., Ryan G.R., Kuroiwa M., Higashi H., Tanaka M., Nairn A.C., Greengard P., Nishi A. Nicotine regulates DARPP-32 (dopamine- and cAMP-regulated phosphoprotein of 32 kDa) phosphorylation at multiple sites in neostriatal neurons. J Pharmacol Exp Ther 2005, 315:872-878.
14. Herdegen T., Leah J.D. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res Brain Res Rev 1998, 28:370-490.
15. Hope B., Kosofsky B., Hyman S.E., Nestler E.J. Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc Natl Acad Sci USA 1992, 89:5764-5768.
16. Hughes P., Dragunow M. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol Rev 1995, 47:133-178.
17. Hyman S.E., Malenka R.C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nat Rev Neurosci 2001, 2:695-703.
18. Janhunen S., Ahtee L. Differential nicotinic regulation of the nigrostriatal and mesolimbic dopaminergic pathways: implications for drug development. Neurosci Biobehav Rev 2007, 31:287-314.
19. Kiba H., Jayaraman A. Nicotine induced c-fos expression in the striatum is mediated mostly by dopaminergic D1 receptor and is dependent on NMDA stimulation. Mol Brain Res 1994, 23:1-13.
20. Konradi C., Leveque J.C., Hyman S.E. Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J Neurosci 1996, 16:4231-4239.
21. Krasnova I.N., Cadet J.L. Methamphetamine toxicity and messengers of death. Brain Res Rev 2009, 60:379-407.
22. Kuribara H. Does nicotine modify the psychotoxic effect of methamphetamine? Assessment in terms of locomotor sensitization in mice. J Toxicol Sci 1999, 24:55-62.
23. Levine A., Huang Y., Drisaldi B., Griffin E.A., Pollak D.D., Xu S., Yin D., Schaffran C., Kandel D.B., Kandel E.R. Molecular mechanism for a gateway drug: epigenetic changes initiated by nicotine prime gene expression by cocaine. Sci Transl Med 2011, 3:107-109.
24. Livingstone P.D., Wonnacott S. Nicotinic acetylcholine receptors and the ascending dopamine pathways. Biochem Pharmacol 2009, 78:744-755.
25. Matta S.G., Balfour D.J., et al. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology 2007, 190(3):269-319.
26. McClung C.A., Ulery P.G., Perotti L.I., Zachariou V., Berton O., Nestler E.J. DeltaFosB: a molecular switch for long-term adaptation in the brain. Brain Res Mol Brain Res 2004, 132:146-154.
27. McCoy M.T., Jayanthi S., Wulu J.A., Beauvais G., Ladenheim B., Martin T.A., Krasnova I.N., Hodges A.B., Cadet J.L. Chronic methamphetamine exposure suppresses the striatal expression of members of multiple families of immediate early genes (IEGs) in the rat: normalization by an acute methamphetamine injection. Psychopharmacology (Berlin) 2011, 215:353-365.
28. Meredith C.W., Jaffe C., Ang-Lee K., Saxon A.J. Implications of chronic methamphetamine use: a literature review. Harv Rev Psychiatry 2005, 13:141-154.
29. Nestler E.J. Review. Transcriptional mechanisms of addiction: role of DeltaFosB. Philos Trans R Soc Lond B Biol Sci 2008, 363:3245-3255.
30. Nestler E.J., Barrot M., Self D.W. DeltaFosB: a sustained molecular switch for addiction. Proc Natl Acad Sci 2001, 98:11042-11046.
31. Neugebauer N.M., Harrod S.B., Bardo M.T. Nicotine elicits methamphetamine-seeking in rats previously administered nicotine. Drug Alcohol Depend 2010, 106:72-78.
32. Perez X.A., O'Leary K.T., Parameswaran N., McIntosh J.M., Quik M. Prominent role of α3/α6β2* nAChRs in regulating evoked dopamine release in primate putamen: effect of long-term nicotine treatment. Mol Pharmacol 2009, 75:938-946.
33. Perez X.A., Ly J., McIntosh J.M., Quik M. Long-term nicotine exposure depresses dopamine release in nonhuman primate nucleus accumbens. J Pharmacol Exp Ther 2012, 342:335-344.
34. Picciotto M.R., Zoli M., Rimondini R., Lena C., Marubio L.M., Pich E.M., Fuxe K., Changeux J.P. Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature 1998, 391:173-177.
35. Pich E.M., Pagliusi S.R., Tessari M., Talbot-Ayer D., van Huijsduijen R.H., Chiamulera C. Common neuronal substrate for the addictive properties of nicotine and cocaine. Science 1997, 275:83-86.
36. Pickens C.L., Airavaara M., Theberge F., Fanous S., Hope B.T., Shaham Y. Neurobiology of the incubation of drug craving. Trends Neurosci 2011, 34:411-420.
37. Sastry B.V., Chance M.B., et al. Distribution and retention of nicotine and its metabolite, cotinine, in the rat as a function of time. Pharmacology 1995, 50(2):128-136.
38. Suemaru K., Gomita Y., Furuno K., Araki Y. Chronic nicotine treatment potentiates behavioral responses to dopaminergic drugs in rats. Pharmacol Biochem Behav 1993, 46:135-139.
39. Yen C.F., Chong M.Y. Comorbid psychiatric disorders, sex, and methamphetamine adolescents: a case-control study. Compr Psychiatry 2006, 47:215-220.
40. Zhang T., Zhang L., Liang Y., Siapas A.G., Zhou F.M., Dani J.A. Dopamine signaling differences in the nucleus accumbens and dorsal striatum exploited by nicotine. J Neurosci 2009, 29:4035-4043.